Who owns CYTEIR THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Cyteir Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cyteir Therapeutics stock

Who bought or sold CYTEIR THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BML Capital Management 3.7M $11M 12% Mar 2024
 View chart
Acadian Asset Management 26k $77k 100% Mar 2024
 View chart
Boston Family Office 24k $73k 0% Mar 2024
 View chart
Lindbrook Capital 2.0k $6.0k 0% Mar 2024
 View chart

Who sold out of Cyteir Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Newtyn Management Dec 2023 3.0M $9.2M
FMR Sep 2023 827k $2.3M
Vanguard Group Dec 2023 687k $2.1M
Millennium Management Dec 2023 452k $1.4M
Walleye Trading Advisors Dec 2023 427k $1.3M
Laurion Capital Management Dec 2023 316k $961k
Brooklyn Capital Management Dec 2023 200k $608k
Geode Capital Management Sep 2023 164k $465k
Aldebaran Capital Sep 2023 144k $408k
Alta Fundamental Advisers Sep 2023 117k $333k
Rbf Capital Sep 2023 117k $333k
Bank of America Corporation Dec 2023 89k $272k
BlackRock Sep 2023 86k $243k
Squarepoint Ops Dec 2023 67k $204k
Bank Of Montreal Dec 2023 66k $204k
CSS Dec 2023 55k $168k
Jane Street Dec 2023 42k $127k
Northern Trust Sep 2023 34k $97k
Wittenberg Investment Management Sep 2023 29k $81k
Caas Capital Management Dec 2023 26k $80k
Hrt Financial Dec 2023 16k $48k
Charles Schwab Investment Management Dec 2023 16k $49k
Landscape Capital Management Dec 2023 13k $40k
Tower Research Capital Sep 2023 6.9k $20k
Royal Bank of Canada Dec 2023 5.4k $16k